FORM 8-K

Company

INTEGRATED BIOPHARMA INC

Filed

November 14, 2024

Period of Report

November 13, 2024

Accession Number

0001437749-24-035331

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →